# Pharmaceutical and Biotech Industry Course: From Molecule Discovery to Market | AI Adoption to Transform Drug Development and Unlock Commercial Growth (March 11th, 2027)

- Published: 2026-11-16
- Author: [Healthcare News](https://healthcarenews.io/author/healthcarenews-io.md)
- Topics: [News](https://healthcarenews.io/news.md)
- Source: https://healthcarenews.io/news/pharmaceutical-and-biotech-industry-course-from-molecule-discovery-to-market-ai-adoption-t/
- Publication: Healthcare News
- Publisher: Connectively (Terkel, Inc.)
- Editorial policy: https://healthcarenews.io/editorial-policy/

*A clear, practical one-day guide to pharma and biotech - from drug discovery to commercialisation, with real-world context and insights into AI's growing role*

Dublin, Nov. 16, 2026 [(GLOBE NEWSWIRE)](https://www.globenewswire.com) -- <a href="https://www.researchandmarkets.com/reports/6261373/how-the-pharmaceutical-biotech-industries-work?utm_source=GNE&amp;utm_medium=PressRelease&amp;utm_code=mq6n5g&amp;utm_campaign=2404195+-+Pharmaceutical+and+Biotech+Industry+Course%3a+From+Molecule+Discovery+to+Market+%7c+AI+Adoption+to+Transform+Drug+Development+and+Unlock+Commercial+Growth+(March+11th%2c+2027)&amp;utm_exec=jocamsai" rel="nofollow">"How the Pharmaceutical and Biotech Industries Work: From Molecule to Market (Mar 11, 2027)"</a> has been added to **ResearchAndMarkets.com's** offering.

This intensive, one-day pharmaceutical and biotechnology industry course provides a clear, structured introduction to the complete drug development lifecycle - from early molecule discovery and clinical development to regulatory approval and commercialisation.

Created for non-scientists, professionals new to the sector, and individuals who work alongside pharmaceutical or biotechnology organisations, the programme offers a practical overview of how the industry operates. Participants will explore the processes, terminology, functions, and decision-making involved in bringing new medicines from initial discovery to the market.

The course examines the key stages of pharmaceutical research and development, highlighting the objectives, challenges, and commercial considerations that influence progress. It also explains how specialist functions contribute throughout the lifecycle, enabling participants to understand the connections between discovery, preclinical development, clinical trials, regulatory affairs, manufacturing, market access, and commercial operations.

By considering how these functions work together in practice, the programme helps attendees develop a broader understanding of cross-functional collaboration within pharma and biotech companies. Participants will gain insight into why critical decisions are made, how development priorities are established, and how scientific, regulatory, operational, and commercial factors affect the potential success of a medicine.

**Industry innovation and artificial intelligence**

Alongside the core principles of pharmaceutical and biotechnology development, the course considers the continuing evolution of the sector. This includes an overview of the growing role of artificial intelligence (AI) in drug discovery, development programmes, and clinical operations.

Participants will examine how AI is influencing research strategies, data analysis, trial planning, and operational efficiency. The programme also considers the implications of these technologies for the future of pharma and biotech, providing relevant context for professionals seeking to understand current industry trends without requiring a scientific background.

**Practical, accessible learning**

The emphasis throughout the day is on clarity, real-world context, and practical understanding - not deep science. Complex topics are presented in a logical sequence, allowing attendees to build their knowledge of the pharmaceutical industry while developing confidence in sector-specific discussions.

The course is particularly relevant for professionals working in business development, finance, human resources, legal services, marketing, communications, procurement, project management, consulting, administration, and other support or commercial roles. It is also suitable for new employees seeking a comprehensive pharmaceutical industry introduction or experienced professionals who require a broader perspective on the drug development process.

By the end of the programme, participants will have a structured understanding of the drug development lifecycle, the responsibilities of major industry functions, and the factors affecting regulatory and commercial outcomes. They will also be better equipped to engage with colleagues, clients, partners, and stakeholders across pharmaceutical and biotechnology organisations.

**CPD Hours: 6**

**Who Should Attend?**  

This course is ideal for anyone who needs a clear, practical understanding of how the pharmaceutical and biotechnology industries work, without requiring a scientific background.

-   New starters entering the pharma or biotech industry
-   Professionals moving into cross-functional, project, or oversight roles
-   Non-scientific, administrative, commercial, IT, and support staff
-   Anyone working with, or alongside, pharmaceutical and biotechnology organisations

**Key Topics Covered:**

-   How medicines are developed
-   Discovery and early development
-   Clinical development
-   Safety and regulation
-   Commercial considerations

**Speaker**

**Laura Brown**

Dr Laura Brown is a pharmaceutical management consultant and Senior Lecturer of the MSc in Clinical Research at the School of Pharmacy, University of Cardiff. Laura has more than 25 years' experience in the pharmaceutical industry and has held senior positions with companies such as GSK, Hoechst Marion Roussel, Farmitalia and Phoenix International. She regularly writes on pharmaceutical drug development and regulatory issues including 'The Planning of International Drug Development' in the Clinical Research Manual and 'The Impact of Brexit' in the RQA journal.

For more information about this training visit <a href="https://www.researchandmarkets.com/reports/6261373/how-the-pharmaceutical-biotech-industries-work?utm_source=GNE&amp;utm_medium=PressRelease&amp;utm_code=mq6n5g&amp;utm_campaign=2404195+-+Pharmaceutical+and+Biotech+Industry+Course%3a+From+Molecule+Discovery+to+Market+%7c+AI+Adoption+to+Transform+Drug+Development+and+Unlock+Commercial+Growth+(March+11th%2c+2027)&amp;utm_exec=jocamsai" rel="nofollow">https://www.researchandmarkets.com/r/tgqlti</a>

**About ResearchAndMarkets.com**  
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: 
CONTACT: ResearchAndMarkets.com 
         Laura Wood,Senior Press Manager 
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470 
         For U.S./ CAN Toll Free Call 1-800-526-8630 
         For GMT Office Hours Call +353-1-416-8900 

  
![](https://ml.globenewswire.com/media/NWY1Mzk3YWYtM2QyNS00YjRhLWEwNWItOGVhM2ZiYjM5ZjIzLTEwMjY3MzctMjAyNi0xMS0xNi1lbg==/tiny/Research-and-Markets.png)

## Related

- [Pharmacovigilance: An Overview of Drug Safety from Safety Collection to Regulatory Inspection (Online Course: Apr 29, 2027) with Graeme Ladds](https://healthcarenews.io/news/pharmacovigilance-an-overview-of-drug-safety-from-safety-collection-to-regulatory-inspecti.md)
- [Global Organ-on-Chip Market Size, Share, Trends and Forecast 2026-2036 | Set to Reach $2.5 Billion as Regulatory Acceptance and Animal Testing Alternatives Drive 22.2% CAGR](https://healthcarenews.io/news/global-organ-on-chip-market-size-share-trends-and-forecast-2026-2036-set-to-reach-2-5-bill.md)
- [Global Bariatric Surgery Devices Market Analysis and Forecast to 2036 | Expected to Reach US$3.42 Billion as Robotic, Endoscopic, and Revisional Procedures Drive Growth Amid GLP-1 Disruption](https://healthcarenews.io/news/global-bariatric-surgery-devices-market-analysis-and-forecast-to-2036-expected-to-reach-us.md)
- [Global Medical AI Apps Market Size and Forecast by Application, End Use and Region (2026-2033) | 19.1% CAGR Fueled by Digital Health and Personalized Care](https://healthcarenews.io/news/global-medical-ai-apps-market-size-and-forecast-by-application-end-use-and-region-2026-203.md)
